A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A
Clinical trial NCT06185335 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06185335
- Sponsor
- Biocad
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-26
- Primary completion
- 2025-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.